secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-08-22T23:59:59+00:00
Accession:  0001193125-23-218037
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex raises ~$650K in private placement of 3.14M shares at $0.207/share
---------------------------------------------------------------------------

- Issued 3,140,095 shares to accredited investors at $0.207 per share for gross proceeds of approximately $650,000.
- Shares sold in unregistered transaction under Section 4(a)(2) and Rule 506 of Regulation D.
- Company to use net proceeds for pepinemab development, working capital, and general corporate purposes.
- Registration rights agreement requires company to file resale registration statement within 120 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523218037/0001193125-23-218037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523218037/d510574d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-218037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer